Article
Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets.
British journal of haematology - 1 May 1996
Silla L M, Pincus S M, Locker J D, Glover J, Elder E M, Donnenberg A D, Nardi N B, Bryant J, Ball E D, Whiteside T L
Abstract excerpt
Activated natural killer (A-NK) cells, a subset of CD56(dim)CD3- lymphocytes, are obtained from PBMC of normal donors by adherence to plastic and culture in the presence of IL2. In this study we tested the feasibility of generating A-NK cells in patients with Ph+ chronic myeloid leukaemia (CML). Cultures obtained from patients with early chronic phase (ECP; n=7) contained a mean (+/-SD) of83 +/- 7% of CD3- cells,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
